Clomipramine in the treatment of catatonia;Tratamiento de la catatonía con clomipramina

Actas Espanolas de Psiquiatria

Volumn 27, Issue 4, 1999, Pages 273-276

  Barroso Canizares A ^a,b   Jimenez Cano J P ^c   Granada Jimenez O ^c  

^a HOSPITAL VIRGEN DE LA SALUD   (Spain)

^b NONE   (Spain)

^c NONE

Author keywords

Affective disorder; Catatonia; Clomipramine

Indexed keywords

CLOMIPRAMINE; SEROTONIN UPTAKE INHIBITOR;

ADOLESCENT; ADULT; ARTICLE; CASE REPORT; CATATONIA; DOSE RESPONSE; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MOOD DISORDER; PSYCHOLOGICAL ASPECT;

ADOLESCENT; ADULT; CATATONIA; CLOMIPRAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; MALE; MOOD DISORDERS; SEROTONIN UPTAKE INHIBITORS;

EID: 0033162133     PISSN: 11399287     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Jhonson J. Catalonia: the tension insanity. Br J Psychiatry 1993;162:733-8.
2. Fein S, McGrath MG. Problems in diagnosing bipolar disorder in catatonic patients. J Clin Psychiatry 1990; 51:203-5.
3. Starkstein SE, Petracca G, et al. Catatonia in depression: prevalence, clinical correlates, and validation of a scale. J Neurol Neurosurg Psychiatry 1996;60(3): 326-32.
4. Gelemberg AJ. The catatonic syndrome. Lancet 1976;2:1339-41.
5. Hawkins JM, Archer KJ, et al. Somatic treatment of catatonia. Int J Psychiatry Med 1995;25:345-69.
6. American Psychiatric Association Practice Guidelines. Practice guideline for major depressive disorder in adults. Am J Psychiatry 1993;(supl)150:1-26.
7. Fink M. Un ensayo de TEC es esencial antes de establecer un diagnóstico de depresión refractaria. En: Amsterdam JD, ed. Depresión Refractaria. Barcelona: Editorial Jims; 1993. p. 93-9.
8. González-Seijo JC, Ramos Vicente YM, et al. Tratamiento de la catatonía con loracepan. Actas Luso-Esp Neurol Psiquiatr 1993;21:90-4.
9. Blanco González AL, Llorca R, et al. Factores afectivos en la evolución de la catatonía: a propósito de dos casos de catatonía en gemelos. Actas Luso-Esp Neurol Psiquiatr 1997;25:341-6.
10. Rankel HW, Rankel LE. Carbamazepine in the treatment of catatonia. Am J Psychiatry 1988;145:361-2.
11. Abrams R, Taylor MA. Catatonia: prediction of response to somatic treatments. Am J Psychiatry 1977; 134:78-80.
12. Albucher RC, De Quardo J, et al. Treatment of catatonia with an anticholinergic agent. Biol Psychiatry 1991;29:513-4.
13. Mahmood T. Bromocriptine in catatonic stupor. Br J Psychiatry 1991;158:437-8.
14. Petrides G, Divadeenan KM, et al. Sinergism of lorazepan and electroconvulsive therapy in the treatment of catatonia. Biol Psychiatry 1997;42:375-81.
15. Taylor MA. Catatonia. A review of a behavioral neurologic syndrome. Neuropsychiat Neuropsychol Behav Neurol 1990;3:48-72.
16. Joseph AB. Catatonia. En: Joseph AB, Young RB. Movement disorders in neurology and neuropsychiatry. Boston: Blackwell Scientific Publications 1992:335-42.
17. Rosebush PI, Hildebrand AM, et al. Catatonic syndrome in a general psychiatric inpatient population: frequency, clinical presentation, and response to lorazepan. J Clin Psychiatry 1990;51:357-62.
18. Fink M, Taylor MA. Catatonia: a separate category for DSM IV? Integrative Psychiatry 1991;7:2-10.
19. Asociación Americana de Psiquiatría. Trastornos del estado del ánimo. En: DSM-IV Manual diagnóstico y estadístico de los trastornos mentales, Barcelona. Masson SA; 1995. p. 345-91.
20. Northoff G, Wenke J, et al. Increase of serum creatine phosphokinase in catatonia: an investigation in 32 acute catatonic patients. Psychol Med 1996;26 (3):547-53.
21. Ries RK. DSM-III implications of the diagnoses of catatonia and bipolar disorder. Am J Psychiatry 1985; 142:1471-4.
22. Hermesh H, Hoffnung RA, et al. Catatonic signs in severe obsessive compulsive disorder. J Clin Psychiatry 1989;50:303-5.
23. Chopra YM, Dandiya PC. The mechanism of the potentiating effect of antidepressant drugs on the protective influence of diphenhidramine in experimental catatonia. The role of histamine. Pharmacology 1974;12:347-53.
24. López-Ibor JJ Jr. Serotonin and psychiatric disorders. Int Clin Psychopharmacol 1992;(supl)7:5-11.
25. Gastpart G. Tratamiento de la depresión con clomipramina. Ciba-Geygi SA, Barcelona: EXPAXS SA, Publicaciones Médicas; 1990.
26. Franz M, Gallhofer B, et al. Treatment of catatonia with intravenous biperidene. Br J Psychiatry 1994; 164:847-8.
27. Wingerson D y Roy-Byrne PP. Review of ansiolytic drugs. En: Dunner DL, ed. Current Psychiatric Therapy. Mexico: WB Saunders Company, Mexico; 1993. p. 295-303.
28. Richelson E. Review of antidepressants in the treatment of mood disorders. En: Dunner DL, ed. Current Psychiatric Therapy. Mexico: WB Saunders Company; 1993. p. 232-9.
29. Paykel ES. Medication and physical treatment of affective disorders. En: Wing JK, Wing L, eds. Handbook of Psychiatry, Psychoses of uncertain aetiology. Vol 3. Cambridge University Press; 1980. p. 166-72.
30. Cook EH Jr, Olson K, et al. Response of organic catatonia to risperidone. Arch Gen Psychiatry 1996;53: 82-3.
31. Leysen JE, Janssen PMF, et al. Risperidone: a novel antipsychotic with balanced serotonin -dopamine antagonism, receptor occupancy profile, and pharmacologie acticity. J Clin Psychiatry 1994;(supl 5):55:5-12.
32. Madhusoodanan S, Brenner R, et al. Efficacy of risperidone treatment for psychoses associated with schizophrenia, schizoaffective disorder, bipolar disorder, or senile dementia in 11 geriatric patients: a case series. J Clin Psychiatry 1995;56:514-8.
33. Leonard BE. The comparative pharmacology of new antidepressants. J Clin Psychiatry 1993;(supl 8):54: 3-15.
34. Stahl S. 5HT1A receptors and pharmacotherapy. Is serotonin receptor down-regulation linked to the mechanism of action of antidepressant drugs? Psychopharmacol Bull 1994;30:39-43.
35. Frazer A. Antidepressants. J Clin Psychiatry 1997; (supl 6):58:9-25.